Cuba launches first nanopharmaceutical

Cuba has unveiled its first manufactured nanopharmaceutical drug—a tweaked variety of cyclosporine, used to help prevent transplant rejection—official media reported Saturday.

"Its main advantages are that it can achieve the same favorable effect with a dose three times less powerful, using the most prescribed drug of its kind in its class, and while significantly reducing side effects," lead researcher Dario Lopez told the Communist Party newspaper Granma.

His research included design of the drug, also used to treat arthritis, "in a totally water soluble form, in which appears dissolved in the form of in microcapsules."

Nanotechnology is a field of applied science in which materials on a tiny scale—structures with at least one dimension sized from 1 to 100 nanometers—are manipulated for industrial, medical and other purposes.

Cuba has a biotech research industry focused largely on vaccines, which earns the Americas' only Communist-run country about $400 million a year.


Explore further

Cuba to test new AIDS vaccine on humans

(c) 2012 AFP

Citation: Cuba launches first nanopharmaceutical (2012, September 23) retrieved 19 June 2019 from https://phys.org/news/2012-09-cuba-nanopharmaceutical.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Sep 23, 2012
Congratulations to our neighbors to the South East. It's long past time we considered normalizing relations with our neighbor countries and a bit less time finding reasons to not get along.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more